Rescue therapy with anti-CD20 treatment in neuroimmunologic breakthrough disease.
Chan
Andrew
A
Lee
De-Hyung
DH
Linker
Ralf
R
Mohr
Alexander
A
Toyka
Klaus V
KV
Gold
Ralf
R
D000328:Adult; D000906:Antibodies / Q000627:therapeutic use*; D018951:Antigens, CD20 / Q000276:immunology*; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D009157:Myasthenia Gravis / Q000188:drug therapy* / Q000276:immunology; D011950:Receptors, Cholinergic / Q000276:immunology
D000906:Antibodies; D018951:Antigens, CD20; D011950:Receptors, Cholinergic
Arch Neurol. 2005 Oct;62(10):1620-3
16216948
Ann Neurol. 2006 Jun;59(6):880-92
16718690
Neurology. 2005 Apr 12;64(7):1270-2
15824362
Neurology. 1983 Oct;33(10):1316-21
6684226
Transfus Sci. 1998 Mar;19 Suppl:43-6
10178693
Arch Neurol. 2005 Feb;62(2):258-64
15710854
Trends Mol Med. 2001 Mar;7(3):115-21
11286782
Lancet. 2005 Aug 13-19;366(9485):579-82
16099294
Annu Rev Immunol. 2006;24:467-96
16551256
Muscle Nerve. 1983 Jun;6(5):386-7
6888417